T L Robertson's research while affiliated with Stanford University and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (2)
The Coronary Artery Surgery Study (CASS) randomized 780 patients to an initial strategy of coronary surgery or medical therapy. Of medically randomized patients, 6% had surgery within 6 months and a total of 40% had surgery by 10 years. At 10 years, there was no difference in cumulative survival (medical, 79% vs. surgical, 82%; NS) and no differenc...
Citations
... 2 Noteworthy that the CASS study in 1970 was the first study to show the benefits of CABG in HF patients over medical treatment. 11 However, this trial was conducted before the era of angiotensin converting enzyme inhibitor, angiotensin II receptor antagonist, angiotensin receptor neprilysin inhibitor and SGLT2 inhibitors, which have especially revolutionized the management and prognosis of HFrEF. To summarize, available data in literature that supported survival benefits of coronary revascularization in HF patients were only observed after a long-term follow-up. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/411353891262464-1475085818485_Q64/Martial-Bourassa.jpg)
